VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.840
+0.030 (3.70%)
Nov 21, 2024, 3:08 PM EST - Market open
VolitionRx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 1.29 | 0.78 | 0.31 | 0.09 | 0.01 | 0.02 | Upgrade
|
| Revenue Growth (YoY) | 97.50% | 153.04% | 240.30% | 570.25% | -21.43% | - | Upgrade
|
| Gross Profit | 1.29 | 0.78 | 0.31 | 0.09 | 0.01 | 0.02 | Upgrade
|
| Selling, General & Admin | 14.91 | 17.21 | 16.75 | 15.4 | 6.73 | 5.7 | Upgrade
|
| Research & Development | 16.36 | 19.55 | 15.33 | 13.02 | 14.53 | 10.36 | Upgrade
|
| Operating Expenses | 31.27 | 36.76 | 32.09 | 28.42 | 21.26 | 16.06 | Upgrade
|
| Operating Income | -29.98 | -35.99 | -31.78 | -28.33 | -21.25 | -16.04 | Upgrade
|
| Interest Expense | -0.31 | -0.22 | -0.17 | -0.16 | -0.13 | -0.13 | Upgrade
|
| Interest & Investment Income | 0.02 | 0.09 | 0.13 | 0 | 0.05 | 0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.11 | 0.45 | 1.23 | 1.52 | 0.64 | 0.16 | Upgrade
|
| EBT Excluding Unusual Items | -30.17 | -35.66 | -30.6 | -26.96 | -20.69 | -15.9 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.03 | -0.02 | - | -0.03 | 0.29 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -0.2 | Upgrade
|
| Pretax Income | -30.2 | -35.68 | -30.6 | -26.99 | -20.4 | -16.1 | Upgrade
|
| Earnings From Continuing Operations | -30.2 | -35.68 | -30.6 | -26.99 | -20.4 | -16.1 | Upgrade
|
| Minority Interest in Earnings | 0.33 | 0.36 | 0.33 | 0.18 | 0.05 | - | Upgrade
|
| Net Income | -29.87 | -35.32 | -30.27 | -26.81 | -20.35 | -16.1 | Upgrade
|
| Net Income to Common | -29.87 | -35.32 | -30.27 | -26.81 | -20.35 | -16.1 | Upgrade
|
| Shares Outstanding (Basic) | 83 | 71 | 55 | 53 | 45 | 39 | Upgrade
|
| Shares Outstanding (Diluted) | 83 | 71 | 55 | 53 | 45 | 39 | Upgrade
|
| Shares Change (YoY) | 26.18% | 28.70% | 5.12% | 16.29% | 15.57% | 24.82% | Upgrade
|
| EPS (Basic) | -0.36 | -0.50 | -0.55 | -0.51 | -0.45 | -0.41 | Upgrade
|
| EPS (Diluted) | -0.36 | -0.50 | -0.55 | -0.51 | -0.45 | -0.41 | Upgrade
|
| Free Cash Flow | -14.53 | -19.15 | -16.85 | -21.83 | -18.41 | -13.25 | Upgrade
|
| Free Cash Flow Per Share | -0.18 | -0.27 | -0.30 | -0.41 | -0.41 | -0.34 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -2331.90% | -4641.76% | -10372.36% | -31468.96% | -158176.25% | -93840.22% | Upgrade
|
| Profit Margin | -2323.23% | -4555.53% | -9879.11% | -29782.49% | -151508.34% | -94168.55% | Upgrade
|
| Free Cash Flow Margin | -1129.84% | -2469.59% | -5498.81% | -24243.33% | -137015.59% | -77507.73% | Upgrade
|
| EBITDA | -28.87 | -34.84 | -30.84 | -27.39 | -20.53 | -15.37 | Upgrade
|
| D&A For EBITDA | 1.11 | 1.15 | 0.94 | 0.95 | 0.72 | 0.68 | Upgrade
|
| EBIT | -29.98 | -35.99 | -31.78 | -28.33 | -21.25 | -16.04 | Upgrade
|
| Revenue as Reported | 1.29 | 0.78 | 0.31 | 0.09 | 0.01 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.